+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Comments

Loading...

Spyre Therapeutics

SYRENASDAQ

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$30.95

2.157.47%

At Close: -

$30.95

00.00%

After Hours: 4:52 PM EDT

15 minutes delayed

Spyre Therapeutics (SYRE) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Spyre Therapeutics (NASDAQ:SYRE) Stock

Spyre Therapeutics Stock (NASDAQ: SYRE)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, July 16, 2024

Evercore ISI Group Initiates Coverage On Spyr...
Benzinga Newsdesk

Tuesday, June 18, 2024

Spyre Therapeutics Has Initiated Dosing Of He...
Benzinga Newsdesk

Wednesday, May 15, 2024

On May 14, 2024, Paragon Therapeutics Announc...
Benzinga Newsdesk

Monday, May 13, 2024

Wells Fargo Maintains Overweight on Spyre The...
Benzinga Newsdesk

Friday, May 10, 2024

BTIG Maintains Buy on Spyre Therapeutics, Rai...
Benzinga Newsdesk

Thursday, May 09, 2024

Spyre Therapeutics Q1 2024 GAAP EPS $(1.20) M...
Benzinga Newsdesk

Thursday, May 02, 2024

Baird Initiates Coverage On Spyre Therapeutic...
Benzinga Newsdesk

Tuesday, March 26, 2024

Stifel Reiterates Buy on Spyre Therapeutics, ...
Benzinga Newsdesk
Stifel Maintains Buy on Spyre Therapeutics, R...
Benzinga Newsdesk

Monday, March 18, 2024

Spyre Therapeutics shares are trading lower a...
Benzinga Newsdesk
Spyre Therapeutics Announces $180M Private Pl...
Benzinga Newsdesk

Tuesday, March 05, 2024

NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor

Friday, March 01, 2024

Spyre Therapeutics shares are trading higher ...
Benzinga Newsdesk
Wells Fargo Upgrades Spyre Therapeutics to Ov...
Benzinga Newsdesk

Thursday, February 29, 2024

Spyre Therapeutics Q4 EPS $(4.05) Up From $(5.00) YoY
Happy Mohamed

Thursday, February 08, 2024

Spyre Therapeutics Announces Three Abstracts ...
Benzinga Newsdesk

Wednesday, December 20, 2023

BTIG Initiates Coverage On Spyre Therapeutics...
Benzinga Newsdesk

Monday, December 18, 2023

Stifel Maintains Buy on Spyre Therapeutics, R...
Benzinga Newsdesk

Monday, December 11, 2023

Guggenheim Initiates Coverage On Spyre Therap...
Benzinga Newsdesk
Jefferies Initiates Coverage On Spyre Therape...
Benzinga Newsdesk

Friday, December 08, 2023

Reported Earlier, Spyre Therapeutics Secures ...
Benzinga Newsdesk

Wednesday, November 29, 2023

TD Cowen Initiates Coverage On Spyre Therapeu...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved